Sumitomo Mitsui DS Asset Management’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-22,173
Closed -$208K – 781
2023
Q1
$208K Hold
22,173
– – ﹤0.01% 747
2022
Q4
$271K Hold
22,173
– – 0.01% 725
2022
Q3
$275K Buy
22,173
+268
+1% +$4.68K 0.01% 713
2022
Q2
$430K Hold
21,905
– – 0.01% 655
2022
Q1
$572K Sell
21,905
-249
-1% -$6.63K 0.01% 625
2021
Q4
$628K Sell
22,154
-82
-0.4% -$2.55K 0.01% 629
2021
Q3
$709K Sell
22,236
-170
-0.8% -$5.7K 0.02% 586
2021
Q2
$777K Hold
22,406
– – 0.02% 573
2021
Q1
$659K Buy
22,406
+112
+0.5% +$3.44K 0.02% 584
2020
Q4
$683K Sell
22,294
-2,653
-11% -$80.9K 0.02% 558
2020
Q3
$696K Buy
24,947
+5,500
+28% +$139K 0.02% 507
2020
Q2
$417K Buy
19,447
+39
+0.2% +$861 0.01% 591
2020
Q1
$434K Buy
19,408
+180
+0.9% +$4.93K 0.02% 528
2019
Q4
$566K Hold
19,228
– – 0.02% 574
2019
Q3
$511K Buy
19,228
+6,284
+49% +$189K 0.02% 560
2019
Q2
$437K Sell
12,944
-4,079
-24% -$132K 0.02% 576
2019
Q1
$545K Buy
+17,023
New +$524K 0.01% 653

Other funds holding ELAN

Sumitomo Mitsui DS Asset Management's ELAN Position: Q2 2023 in Review

Sumitomo Mitsui DS Asset Management sold out of Elanco Animal Health (ELAN) in Q2 2023, closing a stake of 22,173 shares — an estimated $208K sold.

Sumitomo Mitsui DS Asset Management first reported a position in ELAN in Q1 2019 and held it in 17 quarters. The position peaked at $777K in Q2 2021. 352 funds tracked by Wall St. Rank hold ELAN as of Q2 2023.

  • Sumitomo Mitsui DS Asset Management reported no remaining Elanco Animal Health position as of Q2 2023 after selling out during the quarter.
  • Sumitomo Mitsui DS Asset Management sold 22,173 Elanco Animal Health shares in Q2 2023, an estimated $208K.
  • Sumitomo Mitsui DS Asset Management first reported a position in Elanco Animal Health in Q1 2019 and held it in 17 quarters.
  • Sumitomo Mitsui DS Asset Management's Elanco Animal Health position peaked at $777K in Q2 2021.
  • 352 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2023.

Based on Sumitomo Mitsui DS Asset Management's 13F filing for Q2 2023, filed 4 Aug 2023.